The Development and Impact of Hemostatic Stewardship Programs

Kathryn E. Dane, Michael B Streiff, John Lindsley, Manuela Plazas Montana, Satish P Shanbhag

Research output: Contribution to journalReview article


The approval of several new clotting factor concentrates and anticoagulation antidotes has resulted in increased complexity and cost of care. A multidisciplinary hemostatic stewardship program is essential to optimize utilization of these resources. This article summarizes the authors’ approach to the stewardship of clotting factor concentrates and anticoagulation antidotes.

Original languageEnglish (US)
JournalHematology/Oncology Clinics of North America
Publication statusPublished - Jan 1 2019



  • Anticoagulation reversal
  • clotting factor concentrates
  • Hemophilia
  • Stewardship
  • Von Willebrand's disease

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this